PMC:7029158 / 26304-26594 JSONTXT 2 Projects

An updated estimation of the risk of transmission of the novel coronavirus (2019-nCov) Abstract The basic reproduction number of an infectious agent is the average number of infections one case can generate over the course of the infectious period, in a naïve, uninfected population. It is well-known that the estimation of this number may vary due to several methodological issues, including different assumptions and choice of parameters, utilized models, used datasets and estimation period. With the spreading of the novel coronavirus (2019-nCoV) infection, the reproduction number has been found to vary, reflecting the dynamics of transmission of the coronavirus outbreak as well as the case reporting rate. Due to significant variations in the control strategies, which have been changing over time, and thanks to the introduction of detection technologies that have been rapidly improved, enabling to shorten the time from infection/symptoms onset to diagnosis, leading to faster confirmation of the new coronavirus cases, our previous estimations on the transmission risk of the 2019-nCoV need to be revised. By using time-dependent contact and diagnose rates, we refit our previously proposed dynamics transmission model to the data available until January 29th, 2020 and re-estimated the effective daily reproduction ratio that better quantifies the evolution of the interventions. We estimated when the effective daily reproduction ratio has fallen below 1 and when the epidemics will peak. Our updated findings suggest that the best measure is persistent and strict self-isolation. The epidemics will continue to grow, and can peak soon with the peak time depending highly on the public health interventions practically implemented. Introduction Coronaviruses are a group of enveloped viruses with a positive-sense, single-stranded RNA and viral particles resembling a crown – from which the name derives. They belong to the order of Nidovirales, family of Coronaviridae, and subfamily of Orthocoronavirinae (Carlos, Dela Cruz, Cao, Pasnick, & Jamil, 2020). They can affect mammals, including humans, causing generally mild infectious disorders, sporadically leading to severe outbreaks clusters, such as those generated by the “Severe Acute Respiratory Syndrome” (SARS) virus in 2003 in mainland China, and by the “Middle East Respiratory Syndrome” (MERS) virus in 2012 in the Kingdom of Saudi Arabia and in 2015 in South Korea (Gralinski & Menachery, 2020). Currently, there exist no vaccines or anti-viral treatments officially approved for the prevention or management of the disease. Anti-retroviral drugs belonging to the class of protease inhibitors, including Lopinavir and Ritonavir, usually utilized for the treatment of HIV/AIDS patients, seem to exert anti-viral effects against coronaviruses. GS-734 (Remdesivir), a nucleotide analogue pro-drug, originally developed against the Ebola and the Marburg viruses, has been recently suggested to be effective also against coronaviruses. Other potential pharmaceuticals include nucleoside analogues, neuraminidase inhibitors, and RNA synthesis inhibitors. Also, Umifenovir (Abidol), used for treating severe influenza cases, anti-inflammatory drugs and EK1 peptide have been proposed as possible drugs against coronaviruses (Lu, 2020). A recent coronavirus outbreak has started since December 29th, 2019 in Wuhan, Hubei province, People’s Republic of China, and has progressively expanded to various parts of China and has reached as well other countries, including Japan, South Korea, Thailand, Vietnam, Malaysia, Singapore, Nepal, Cambodia, the Philippines, Russia, the United Arab Emirates, Australia, Canada, the United States of America and Europe (France, Germany, Italy, UK, Finland and Sweden). So far, the new virus has infected more than 31,000 people and killed at least 636 of them (National Health Commission of the People’s Republic of China, 2020). While considerable progress has been achieved with respect to seventeen years ago, when the world had to face, completely unprepared, the SARS pandemics, several issues still remain to cope with. In order to respond swiftly and properly to the outbreak, public health decision- and policy-makers need timely and accurate epidemiological information, concerning, for example, how long it may take from exposure to the virus to illness/symptoms onset or which individuals, with specific characteristics or co-morbidities, are at higher risk of a poor prognosis. However, many data are still lacking and available data may not be accurate or reliable and may contain substantial uncertainty, concerning, for instance, the precise timing and natural history of cases. Simulating different scenarios with evolving knowledge and gradually improved data quality present significant challenges for modelers. On the other hand, scenario analysis could help ruling out some (unrealistic or over optimistic) assumptions, enabling to test different hypotheses. As recognized by the World Health Organization (WHO), mathematical models, especially those devised in a timely fashion, can play a key role in providing health decision- and policy-makers with evidence-based information. Modeling can, indeed, better help understanding: i) how transmissible the disease is, ii) when the infectiousness is highest during the course of infection, iii) how severe the infection is, and iv) how effective interventions have been and ought to be. The international community of modelers has accepted the challenge of designing mathematical models of coronavirus dynamics and transmission and has swiftly reacted to the current coronavirus outbreak. Several models have been produced, resulting, sometimes, in different estimates. Previously, our group has devised a deterministic compartmental (SEIR) model (Tang et al., 2020). In the present article, we update this model, based on the latest available data and information. Methods Time-dependent dynamic model On January 23rd, 2020, Wuhan, the epicenter of the current coronavirus outbreak, announced the implementation of travel restriction as strategy for controlling the infection. Following this announcement, many other cities and provinces of China decided to enforce similar measures. In the meantime, many other control measures have been adopted, like convincing all the residents to stay at home and avoid contacts as much as possible. From the mathematical point of view, this can significantly contribute to decreasing the contact rate c among the persons. On the other hand, also from January 23rd, 2020, gradually increasing numbers of 2019-nCoV testing kits were sent to Wuhan from other provinces, gradually shortening the time period of diagnosis (i.e. the value of δI increases greatly). Considering these control strategies, we adapted our previous model (Tang et al., 2020) as time-dependent dynamic system, by taking January 23rd, 2020 as the newly initial time:S’=−(βc(t)+c(t)q(1−β))S(I+θA)+λSq,E’=βc(t)(1−q)S(I+θA)−σE,I’=σϱE−(δI(t)+α+γI)I,A’=σ(1−ϱ)E−γAA,Sq’=(1−β)c(t)qS(I+θA)−λSq,Eq’=βc(t)qS(I+θA)−δqEq,H’=δI(t)I+δqEq−(α+γH)H,R’=γII+γAA+γHH, Here, we assume that the contact rate c(t) is a decreasing function with respect to time t, which is given byc(t)=(c0−cb)e−r1t+cb,where c0 is the contact rate at the initial time (i.e. January 23rd, 2020), cb is the minimum contact rate under the current control strategies, and r1 is the exponential decreasing rate of the contact rate. Definitely, there are c(0)=c0 and limt→∞c(t)=cb with cbAccurately near-casting the epidemic trend and projecting the peak time require real-time information of the data and the knowledge about the implementation and the resources available to facilitate the implementation, not only the policy and decision, of major public health interventions. Funding This research was funded by the 10.13039/501100001809National Natural Science Foundation of China (grant numbers: 11631012 (YX, ST), 61772017(ST)), and by the Canada Research Chair Program (grant number: 230720 (JW) and the 10.13039/501100000038Natural Sciences and Engineering Research Council of Canada (Grant number:105588-2011 (JW). Declaration of competing interest None. Acknowledgement We all appreciate the joint support by the 10.13039/501100004519Tianyuan Mathematical Center in Northwest China, the 10.13039/501100000020Fields Institute for Research in Mathematical Sciences, and the Mathematics for Public Health (MfPH) Laboratory (Fields-CQAM). Peer review under responsibility of KeAi Communications Co., Ltd.

Document structure show

Annnotations TAB TSV DIC JSON TextAE

last updated at 2021-01-31 05:44:32 UTC

  • Denotations: 0
  • Blocks: 0
  • Relations: 0